The Company is currently looking to facilitate its corporate transformation from a bio-pharma R&D business into a revenue-generating company.
Latest News
January 30, 2012
Pacgen Expands PAC-113 License
January 25, 2012
Pacgen Closes Private Placement Financing
January 12, 2012
Pacgen Reports on Private Placement
January 10, 2012
Pacgen Reports on Annual and Special Shareholder Meeting




